U.S. Ramps Up Drug War in Afghanistan

The following excerpt is from an article that originally appeared on The Economic Crisis Report

DoDWashington has spent more than $8 billion on counternarcotics efforts in Afghanistan since 2002, and it has a record-breaking poppy season in 2017 to show for it. Naturally, it plans to double down

The top American commander in Afghanistan, Gen. John Nicholson, announced yesterday that U.S. airstrikes are now targeting drug labs in that country. This is the first time the U.S. has used F-22s, which cost $340 million apiece, in Afghanistan, and it’s the first time U.S. forces have used their new power—granted by President Donald Trump in August—to order airstrikes against Taliban revenue streams. (Previously such strikes could be used only to defend U.S. or allied forces or positions.)

Seven drug labs were bombed in this week’s campaign. The Drug Enforcement Administration estimates that there are as many as 500 opium labs across Afghanistan.

Nicholson stressed that the drug war in Afghanistan won’t make much of a dent

Click here to Read this Entire Story on The Economic Crisis Report


This post was originally published on this site
Comments are closed.